Nektar Therapeutics | NKTR - Betriebsergebnis

Aktienkurs
72.22
Täglich Wechseln
-2.62 -3.50%
Monatlich
-1.90%
Jährlich
457.45%
Q1 Prognose
70.05




Betriebsergebnis Veränderung Datum
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Amgen USD 3.96B 464M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 659.6M 192.2M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Cara Therapeutics USD -2.39M 3.49M 2025-03
Cipla INR 9.77B 6.21B 2025-12
Dr.Reddys Laboratories INR 13.94B 2.31B 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 383.88M 47.43M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -31.28M 5M 2024-12
MacroGenics USD -12.1M 30.74M 2025-12
Merck USD 6.24B 318M 2025-12
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 437M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Takeda JPY 168.82B 479.89B 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Xencor USD -53.63M 6.11M 2025-12